📰 Human Use News
Page 79 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
April 5, 2023
By Denny Jacob InflaRx NV shares were on pace Wednesday for its best three-day stretch on record, a day after Gohibic, a monoclonal anti-human complement factor C5a antibody it is developing,... | April 5, 2023
April 5, 2023
Biopharmaceutical company InflaRx NV's monoclonal antibody has been granted emergency use authorization (EUA) by the Food and Drug Administration (FDA) for the treatment of COVID-19 ...
April 5, 2023
Though much attention has been given recently to certain artists’ experimentations with AI, best described and dismissed as spectacle (in the true Debord sense), any number of artists have challenged and even mocked the technology and its specious claims to neutral operating systems or unconditional utility.
April 4, 2023
SHELTON, CT / ACCESSWIRE / April 4, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in nanomedicines against viruses, announced today that it has executed a License Agreement
April 4, 2023
Data from the PANORAMA-HF and PARADIGM-HF trials support the recommendation for approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.
April 4, 2023
A branch of the European Medicines Agency recommended Briumvi, a one-hour infusion treatment for relapsing MS forms, be approved for adults.
April 4, 2023
PRESS RELEASE AB SCIENCE ANNOUNCES THAT IT HAS SUBMITTED ITS RESPONSE TO THE DAY 120 QUESTIONS IN THE EMA REGULATORY REVIEW OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS AND CLARIFIES THE NEW... | April 4, 2023
April 4, 2023
Vilobelimab is the first authorized drug to control complement factor C5a, a protein that plays an important and often harmful role in the body's immune...
April 4, 2023
IFRX-Small-Talk - gustl2019 schreibt: Morgen wird es interessant. - Aktuellster Kommentar zur Diskussion. Diskutiere mit unserer Börsennews-Community.
April 4, 2023
By Denny Jacob InflaRx NV on Tuesday said Gohibic, a monoclonal anti-human complement factor C5a antibody, was granted emergency use authorization by the Food and Drug Administration. The... | April 4, 2023